Relationships between the visceral fat area on CT and coronary risk factor markers

Internal Medicine

Volumn 52, Issue 16, 2013, Pages 1775-1780

  Shiina, Yutaka ^a   Homma, Yasuhiko ^a  

^a TOKAI UNIVERSITY   (Japan)

Author keywords

Adiponectin; MDA LDL; Small dense LDL; Visceral fat area

Indexed keywords

ADIPONECTIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HOMEOSTASIS; HUMAN; INTRAABDOMINAL FAT; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; TURBIDIMETRY; WAIST CIRCUMFERENCE;

AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; CORONARY ARTERY DISEASE; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; WAIST CIRCUMFERENCE;

EID: 84881603928     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.52.9190     Document Type: Article

References (24)

1. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486-2497, 2001.
2. Part I: Diagnosis and Classification of Diabetes Mellitus. In: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. World Health Organization, Geneva, 1999.
3. Alberti KGMM, Zimmet P, Shaw J, et al. The metabolic syndrome: a new worldwide definition. Lancet 366: 1059-1062, 2005.
4. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120: 1640-1645, 2009.
5. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decresed of an adipo-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257: 79-83, 1999.
6. The Examination Committee of Criteria for Obesity Disease in Japan, Japan Society for the Study of Obesity. New criteria for obesity disease in Japan. Circulation J 66: 987-992, 2002.
7. Yoshizumi T, Nakamura T, Yamane M, et al. Abdominal fat: standardized technique for measurement at CT. Radiology 211: 283-286, 1999.
8. Kotani K, Maekawa M, Kanno T, et al. Distribution of immunoreactive malondialdehyde-modified low-density lipoprotein in human serum. Biochim Biophys Acta 1215: 121-125, 1994.
9. Nakajima K, Saito T, Tamura A, et al. Choresterol in remnant-like lipoproteins in human serum using monoclonal antiapoB-100 and antiapoA-I immunoaffinity mixed gel. Clin Chim Acta 223: 53-71, 1993.
10. Noma A, Hara Y, Goto Y. Quantification of serum apolipoprotein A-I, A-II, B, C-II, C-III, and E in healthy Japanese by the turbidimetric immunoassay: reference values, and age-and sex-related differences. Clin Chim Acta 199: 147-157, 1991.
11. Miyawaki T, Abe M, Yahata K, et al. Contribution of visceral fat accumulation to the risk factors for atherosclerosis in non-obese Japanese. Intern Med 43: 1138-1144, 2004.
12. Matsuzawa Y, Funahashi T, Kihara S, et al. Adiponectin and Metabolic Syndrome. Arterioscler Thromb Vasc Biol 24: 29-33, 2004.
13. Ryo M, Nakamura T, Kihara S, et al. Adiponectin as a biomarker of the metabolic syndrome. Circulation J 68: 975-981, 2004.
14. Ohnishi H, Saitoh S, Akasaka H, et al. Incidence of hypertension in individuals with abdominal obesity in a rural Japanese population: The Tanno and Sobetsu study. Hypertens Res 31: 1385-1390, 2008.
15. Lamarche B, Tchernof A, Mauriege P, et al. Fasting insulin and Apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA 279: 1955-1961, 1998.
16. Kinoshita M, Ohnishi H, Maeda T, et al. Increased serum apolipoprotein B48 concentration in patients with metabolic syndrome. J Atheroscler Thromb 16: 517-522, 2009.
17. Matsuura F, Yamashita S, Nakamura T, et al. Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism 47: 929-933, 1998.
18. Twickler TB, Dallinga-Thie GM, Cohn JS, Chapman MJ. Elevated remnant-like particle cholesterol concentration: a characteristic feature of the atherogenic lipoprotein phenotype. Circulation 109: 1918-1925, 2004.
19. McNamara JR, Shah PK, Nakajima K, et al. Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: result from the Framingham Heart Study. Atherosclerosis 154: 229-236, 2001.
20. Holvoet P, Perez G, Zhao Z, et al. Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease. J Clin Invest 95: 2611-2619, 1995.
21. de Gtaaf J, Hak-Lemmers HL, Hectors MP, et al. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 11: 298-306, 1991.
22. Boerwinkle E. Genetics of plasma lipoprotein(a) conentrations. Curr Opinion Lipidol 3: 128-136, 1992.
23. Simons L, Friedlander Y, Simons J, et al. Lipoprotein(a) is not associated with coronary heart disease in elderly: cross-sectional data from the Dubbo study. Atherosclesosis 99: 87-95, 1993.
24. Homma Y. Predictors of atherosclerosis. J Atheroscler Thromb 11: 265-270, 2004.